Updated
Updated · TradingView · Jul 13
Bempikibart Cuts Severe Alopecia Score 35.3% at 36 Weeks as 40% Regrow Hair
Updated
Updated · TradingView · Jul 13

Bempikibart Cuts Severe Alopecia Score 35.3% at 36 Weeks as 40% Regrow Hair

3 articles · Updated · TradingView · Jul 13

Summary

  • At 36 weeks, bempikibart delivered a 35.3% mean reduction in SALT score in severe alopecia areata, with 40% of patients achieving significant hair regrowth.
  • The study also reported a favorable safety profile, alongside early signs of durability that support continued treatment development.
  • Robust pharmacokinetic and anti-drug antibody data added to the case for further development of the therapy in severe alopecia areata.

Insights

Could this new drug offer lasting hair regrowth without the continuous treatment and risks of current therapies?
Why did this new alopecia drug's stock surge when its regrowth rates seem similar to existing market leaders?